A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Clinical trial NCT07288138 · RECRUITING
Trial details
- NCT number
- NCT07288138
- Sponsor
- Eccogene
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2027-09-15
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.